
1.62 Delayed Data As of Mar 24 | ![]() Today’s Change | 1.45 Today|||52-Week Range 10.30 | -9.50% Year-to-Date |
The 2 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +517.28% increase from the last price of 1.62.
The current consensus among 2 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.